CD73-IN-3 T8875
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.
CAS nr:
2375815-63-5
Purity:
98%
Molecular Weight:
286,33
SMILES:
CC1=NN=C(C=C1[C@H]2C[C@@H]2C(C)C)C3=CNC(=O)NC3=O
Formula:
C15H18N4O2
Pathway:
Others
Target:
Others
